SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC rises on reporting 26.34% rise in Q2 net profit

05 Nov 2012 Evaluate

FDC is currently trading at Rs. 87.75, up by 0.30 points or 0.34% from its previous closing of Rs. 87.45 on the BSE.

The scrip opened at Rs. 87.80 and has touched a high and low of Rs. 89.50 and Rs. 86.65 respectively. So far 70197 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 95.65 on 12-Sep-2012 and a 52 week low of Rs. 75.00 on 14-May-2012.

Last one week high and low of the scrip stood at Rs. 89.50 and Rs. 84.15 respectively. The current market cap of the company is Rs. 1608.54 crore.

The promoters holding in the company stood at 67.17% while Institutions and Non-Institutions held 12.42% and 20.42% respectively. 

FDC has reported 26.34% rise in its net profit at Rs 46.52 crore for the quarter ended September 30, 2012 as compared to Rs 36.82 crore for the same quarter in the previous year.  Total income of the company has increased by 5.12% at Rs 208.13 crore for quarter under review as compared to Rs 198.00 crore for the quarter ended September 30, 2011.

FDC make modest beginning in 1936, with marketing of vitamins and a range of prescription formulations. FDC set up its first formulations manufacturing facility in 1949. Subsequently, in 1963, FDC pioneered the manufacture of specialized ophthalmic formulations in India.

FDC Share Price

366.60 -5.70 (-1.53%)
24-Apr-2026 09:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1643.35
Dr. Reddys Lab 1323.15
Cipla 1286.00
Zydus Lifesciences 935.20
Lupin 2327.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×